The Amsler chart: Absence of evidence is not evidence of absence

British Journal of Ophthalmology

Volumn 91, Issue 3, 2007, Pages 391-393

  Crossland, Michael ^a,b   Rubin, Gary ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC PROCEDURE; DISEASE COURSE; HEALTH CARE PERSONNEL; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RETINA MACULOPATHY; SCOTOMA; SHORT SURVEY; VISUAL ACUITY; EARLY DIAGNOSIS; LABORATORY DIAGNOSIS; METHODOLOGY; PSYCHOLOGICAL ASPECT; RETINA MACULA DEGENERATION; REVIEW; VISION; VISION TEST;

DISEASE PROGRESSION; EARLY DIAGNOSIS; FALSE NEGATIVE REACTIONS; HUMANS; MACULAR DEGENERATION; PERCEPTUAL CLOSURE; VISION SCREENING; VISION TESTS;

EID: 33947601841     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.095315     Document Type: Short Survey

References (38)

1. Chang TS, Tonnu IQ, Globe DR, et al. Longitudinal changes in self-reported visual functioning in AMD patients - in a randomised controlled phase I/II trial of lucentis (TM) (ranizumab, rHuFAB v2). Invest Ophthalmol Vis Sci. 2004;45: ARVO E-Abstract, 3098.
2. Moshfeghi AA, Puliafito CA. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration. Expert opinion on Investigational Drugs 2005;14:671-682.
3. Schmidt-Erfurth U, Michels S, Michels R, et al. Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. European journal of ophthalmology 2005;15:482-485.
4. Schlaegel TF, Cofield DD, Clark G, et al. Photocoagulation and other therapy for histoplasmic choroiditis: An etiologic survey of 100 patients. Ophthalmology 1968;79:355-363.
5. Amsler M. L'examen qualitatif de la fonction maculaire. Ophthalmologic 1947;114:248-61.
6. Amsler M. Earliest symptoms of diseases of the macula. Brit J Ophthalmol 1953;37:521-537.
7. Marmor MF. A brief history of macular grids: From Thomas Reid to Edvard Munch and Marc Amsler. Survey of Ophthalmology 2000;44:343-353.
8. Forster R. Zur klinischen Kenntniss des Choroiditis syphilitica. Graefes Arch Clin Exp Ophthalmol 1874;20:33-82.
9. Mackay G. Ophthal Rev 1894;13:83.
10. Amsler M. Amsler charts manual. London: Hamblin Instruments, 1949.
11. Loewenstein A, Malach R, Goldstein M, et al. Replacing the Amsler grid - a new method for monitoring patients with age-related macular degeneration. Ophthalmology 2003;110:966-970.
12. Schuchard RA. Validity and interpretation of amsler grid reports. Arch Ophthalmol 1993;111:776-780.
13. Fine AM, Elman MJ, Ebert EM, et al. Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol 1986;104:513-514.
14. Zaidi FH, Cheong-Leen R, Gair EJ, et al. The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London Survey. Eye 2004;18:503-8.
15. Timberlake GT, Mainster MA, Peli E, et al. Reading with a macular scotoma. I. Retinal location of scotoma and fixation area. Invest Ophthalmol Vis Sci 1986;27:1137-47.
16. Sunness JS, Applegate CA, Haselwood D, et al. Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease. Ophthalmology 1996;103:1458-1466.
17. Crossland MD, Culham LE, Kabanarou SA, et al. Preferred retinal locus development in patients with macular disease. Ophthalmology 2005;112:1579-1585.
18. Parkes L, Lund J, Angelucci A, et al. Compulsory averaging of crowded orientation signals in human vision. Nat Neurosci 2001;4:739-44.
19. He S, Cavanagh P, Intriligator J. Attentional resolution and the locus of visual awareness. Nature 1996;383(6598):334-7.
20. Brewster D. Letters on natural magic, addressed to Sir Walter Scott. London: John Murray, 1832.
21. Walls GL. The filling-in process. Am J Optom Arch Am Acad Optom 1954;31:329-341.
22. Komatsu H. The neural mechanisms of perceptual filling-in. Nature reviews neuroscience 2006;7:220-231.
23. Safran AB, Landis T. From cortical plasticity to unawareness of visual field defects. J Neurophthalmol 1999;19:84-88.
24. Gerrits HJM, Timmerman GJMEN. The filling-in process in patients with retinal scotomata. Vision res 1969;9:439-442.
25. Schuchard RA. Perceptual Completion of Patterns across Scotomas. Investigative Ophthalmology & Visual Science 1993;34:1420- 1420.
26. Ramachandran VS, Gregory RL. Perceptual filling in of artificially induced scotomas in human vision. Nature 1991;350:699-702.
27. Zur D, Ullman S. Filling-in of retinal scotomas. Vision Res 2003;43:971-82.
28. Augustin AJ, Offermann I, Lutz J, et al. Comparison of the original Amsler grid with the modified Amsler grid: Result for patients with age-related macular degeneration. Retina 2005;25:443-445.
29. Wall M, Sadun AA. Threshold Amsler grid testing. Cross-polarizing lenses enhance yield. Arch Ophthalmol 1986;104:520-3.
30. Wolfe KA, Sadun AA. Threshold Amsler grid testing in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1991;229:219-223.
31. Mutlukan E. Red dots visual field test with blue on yellow & blue on red macula test grid. Eye 2005;20:506-507.
32. Yannuzzi LA. A modified Amsler grid: A self-assessment test for patients with macular disease. Ophthalmology 1982;89:157-159.
33. Preferential Hyperacuity Perimeter Research Group. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina 2005;25:296-303.
34. Alster Y, Bressler NM, Bressler SB, et al. Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study. Ophthalmology 2005;112:1758-65.
35. Office of National Statistics. Living in Britain: Results from the 2001 General Household Survey. London: The Stationery Office, 2002.
36. Plummer DJ, Azen SP, Freeman WR. Scanning laser entoptic perimetry for the screening of macular and peripheral retinal disease. Archives of Ophthalmology 2000;118:1205-1210.
37. Freeman WR, El-Bradey M, Plummer DJ. Scanning laser entoptic perimetry for the detection of age-related macular degeneration. Arch Ophthalmol 2004;122:1647-1651.
38. Trauzettel-Klosinski S, Biermann P, Hahn G, et al. Assessment of parafoveal function in maculopathy: a comparison between the Macular Mapping Test and kinetic Manual Perimetry. Grafe's Arch Clin Exp Ophthalmol 2003;241:988-995.